The agent successfully assembled a coherent explanation of PZ's purpose, audience, and subscription model, but had to work around the site's intentional hiding of pricing behind an external vendor (GOVI). The site published its core identity and subscription options clearly enough to fetch; PZ's strategic opacity on costs appears deliberate rather than accidental.

• ›Step [1] and [4] (homepage fetches) returned complete service and content overview; the site is well-structured for identity discovery. The agent extracted what PZ *is* (professional news journal) and who it serves (pharmacists, students, interns) directly from published navigation and section labels.
• ›Step [7] (subscription service page) confirmed subscription tiers and contact information but pointedly omitted prices. The site explicitly delegates pricing to GOVI (govi.de), a third-party distributor. This is a deliberate architectural choice, not a navigation failure.
• ›Step [5] and [6] (web searches) revealed that alternatives like *Archiv der Pharmazie* and *Die Pharmazie* are academic research journals, not professional news outlets. The agent correctly positioned PZ as a different product category (journalism vs. peer-reviewed research), but this positioning came from search results, not from PZ's own marketing language on the site.
• ›The agent encountered two hard 404s ([2], [3]) on guessed URLs (/abos, /about), showing the site does not publish traditional About or pricing-landing pages. Information had to be assembled from homepage sections and the subscription service page.
• ›The final answer cites only site-hosted URLs ([7] and GOVI links found via search [5]), yet the competitive differentiation claim depends on search-derived understanding of peer journals. The site itself never explicitly positions PZ against alternatives; this narrative was built from external context.